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Abstract. 
 
The ﬁrst 10 residues within the Src homology 
domain (SH)–4 domain of the Src family kinase Fyn are 
required for binding to the immune receptor tyrosine-
based activation motif (ITAM) of T cell receptor 
(TCR) subunits. Recently, mutation of glycine 2, cys-
teine 3, and lysines 7 and 9 was shown to block binding 
of Fyn to TCR 
 
z
 
 chain ITAMs, prompting the designa-
tion of these residues as an ITAM recognition motif 
(Gauen, L.K.T., M.E. Linder, and A.S. Shaw. 1996. 
 
J
 
.
 
 
Cell Biol
 
. 133:1007–1015). Here we show that these res-
idues do not mediate direct interactions with TCR 
ITAMs, but rather are required for efﬁcient myristoyla-
tion and palmitoylation of Fyn. Speciﬁcally, coexpres-
sion of a K
 
7,9
 
A-Fyn mutant with 
 
N
 
-myristoyltransferase 
restored myristoylation, membrane binding, and associ-
ation with the cytoplasmic tail of TCR 
 
z
 
 fused to CD8. 
Conversely, treatment of cells with 2-hydroxymyristate, 
a myristoylation inhibitor, blocked association of wild-
type Fyn with 
 
z
 
. The Fyn NH
 
2
 
 terminus was necessary 
but not sufﬁcient for interaction with 
 
z
 
 and both Fyn ki-
nase and SH2 domains were required, directing phos-
phorylation of 
 
z
 
 ITAM tyrosines and binding to 
 
z
 
 
ITAM phosphotyrosines. Fyn/
 
z
 
 interaction was sensi-
tive to octylglucoside and ﬁlipin, agents that disrupt 
membrane rafts. Moreover, a plasma membrane bound, 
farnesylated Fyn construct, G
 
2
 
A,C
 
3
 
S-FynKRas, was not 
enriched in the detergent insoluble fraction and did not 
associate with 
 
z
 
. We conclude that the Fyn SH4 domain 
provides the signals for fatty acylation and speciﬁc 
plasma membrane localization, stabilizing the interac-
tions between the Fyn SH2 domain and phosphoty-
rosines in TCR 
 
z
 
 chain ITAMs.
Key words: Src homology domains • acylation • cell 
membrane • protein-tyrosine kinase • receptor/
antigen
 
P
 
ROTEINS
 
 belonging to the Src family of nonreceptor
tyrosine kinases critically rely on binding to the cy-
toplasmic leaflet of the plasma membrane lipid bi-
layer to fulfill their biological functions (32, 40). Mem-
brane targeting is specifically guided by the Src homology
domain (SH)
 
1
 
–4 motif, a short sequence in the NH
 
2
 
-termi-
nal region of Src family kinases (30, 31). SH4 motifs con-
tain two independent signals (myristate and either palmi-
tate or a polybasic amino acid sequence) that control
stable membrane attachment when acting together, but
not when operating individually (31, 32). For example,
specific and rapid plasma membrane targeting of the Src
family kinase Fyn is encoded by dual fatty acylation with
myristate at glycine 2 and palmitate at cysteine 3 (1, 35,
41, 43).
Protein myristoylation involves the cotranslational at-
tachment of the 14 carbon fatty acid myristate to the NH
 
2
 
-
terminal glycine (glycine 2) on target proteins (8, 17,
42). A chemically stable amide bond is formed between
myristate and glycine and is maintained for the lifetime of the
protein. The enzymatic reaction is catalyzed by 
 
N
 
-myri-
stoyl transferase (NMT), a cytosolic protein that is ubiqui-
tously expressed in eukaryotic cells. The minimum consen-
sus sequence for 
 
N
 
-myristoylation is GXXXS/T; glycine 2
is a critical component and a serine or threonine at posi-
tion 6 is preferred (17). Additional amino acids have been
shown to be important for recognition by NMT in the con-
text of specific protein sequences. 
 
N
 
-myristoylation of Fyn
is a prerequisite for posttranslational and dynamic palmi-
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ITAM, immune-receptor tyrosine-based activation motif; NMT, 
 
N
 
-myri-
stoyl transferase; SH, Src homology domain; TCR, T cell receptor. 
The Journal of Cell Biology, Volume 145, 1999 378
 
toylation to occur. Mutations that ablate myristoylation
result in loss of palmitoylation (1, 35, 41, 43). Efficient
myristoylation of Fyn, therefore, is essential for correct
processing and intracellular targeting of Fyn (41, 43).
One of the functional consequences of dual fatty acyla-
tion and plasma membrane targeting is to allow Src family
kinases to interact with transmembrane receptor com-
plexes. For example, Fyn coimmunoprecipitates with the
activated T cell receptor (TCR) and has been reported to
interact with multiple TCR subunits (10, 33). Fyn tyrosine
kinase activity is stimulated when the TCR is cross-linked,
but the molecular nature of the Fyn/TCR interaction is
not entirely clear, as the complex is only detected by the
use of mild detergents to lyse cells (10, 33, 40). The pres-
ence of immune receptor tyrosine-based activation motifs
(ITAM) on the 
 
z
 
 chain of the TCR was shown to be essen-
tial for interaction with Fyn, although no specific amino
acid within the ITAM seemed to be responsible for this in-
teraction (12). Recently, mutation of glycine 2, cysteine 3,
and lysines 7 and 9 within the SH4 domain of Fyn was re-
ported to block binding to the 
 
z
 
 chain of the TCR, prompt-
ing the designation of these four resides as an ITAM rec-
ognition motif (11). However, glycine 2 is required for
myristoylation and cysteine 3 is the main site of palmitoy-
lation in Fyn (1, 35, 43). In addition, lysine 7 has been im-
plicated in directing efficient myristoylation of Src (6, 19).
Thus, it remained possible that alteration in fatty acylation
levels was responsible for the inability of the mutant Fyn
to interact with 
 
z
 
 chain.
We therefore reevaluated the role of the SH4 motif of
Fyn, focusing on the significance of lysines 7 and 9 in fatty
acylation and membrane targeting of Fyn, and its interac-
tions with the TCR 
 
z
 
 chain. Here we show that dual fatty
acylation of a K
 
7,9
 
A-Fyn mutant was drastically impaired.
A gain of function experiment revealed that overexpres-
sion of NMT restored fatty acylation levels of K
 
7,9
 
A-Fyn
and allowed the mutant protein to interact with the cyto-
plasmic tail of the TCR 
 
z
 
 chain fused to CD8. Using the
myristoylation inhibitor 2-hydroxymyristate, we observed
that association of wild-type Fyn with the 
 
z
 
 chain can be
disrupted by blocking fatty acylation. The Fyn NH
 
2
 
 termi-
nus was necessary but not sufficient for interaction with 
 
z
 
.
Both functional Fyn kinase and SH2 domains were re-
quired, directing phosphorylation of 
 
z
 
 ITAM tyrosines and
subsequent binding of the Fyn SH2 domain to 
 
z
 
 ITAM
phosphotyrosines. The interactions between Fyn and 
 
z
 
were sensitive to conditions that disrupt membrane rafts
and a farnesylated Fyn construct that was not enriched in
the detergent insoluble fraction did not stably associate
with 
 
z
 
.
These results provide additional explanations for the se-
quence requirements and mild detergent conditions needed
for coimmunoprecipitation of Fyn with TCR subunits. We
conclude that dually fatty acylation of Fyn is required for
correct targeting to specific membrane subdomains, that is
a prerequisite for stable association with the cytoplasmic
tail of the TCR 
 
z
 
 chain. Fyn kinase activity is required for
phosphorylation of tyrosine residues in the ITAMs of the
 
z
 
 chain, to which the Fyn SH2 domain subsequently binds.
The localization of Fyn in plasma membrane rafts there-
fore serves an essential role in stabilizing SH2–phosphoty-
rosine interactions between Fyn and TCR 
 
z
 
.
 
Materials and Methods
 
Materials
 
Cell culture reagents were purchased from Gibco Laboratories. cDNAs
for human wild-type Fyn, G
 
2
 
A-Fyn, and C
 
3,6
 
S-Fyn (1) and NMT (28) and
rabbit polyclonal antiserum raised against Fyn SH43 protein (3) were
from lab stocks. pEFBOS-CD8-
 
z
 
, CD8-
 
z
 
T76, and CD8-
 
z
 
4F (16, 22) were
kindly donated by Dr. Arthur Weiss (Department of Immunology, Uni-
versity of California, San Francisco, San Francisco, CA). pSV
 
D
 
SH2-Fyn,
containing mutant Fyn lacking amino acids 144–248, was kindly provided
by Drs. Nicolas Dunant and Kurt Balmer-Hofer (Friedrich Miescher Insti-
tute, Basel, Switzerland). pEGFP-N1 and rabbit polyclonal antibody
against green fluorescent protein (GFP) were obtained from Clontech.
Anti–CD8 monoclonal antibody solution and high purity digitonin were
from Calbiochem. Protein A–agarose and protein A/G
 
1
 
 agarose beads and
antiphosphotyrosine (PY99) monoclonal antibody solution were purchased
from Santa Cruz Biotechnology. 
 
DL
 
-
 
a
 
-Hydroxymyristic acid (2-hydroxy-
tetradecanoic acid), defatted BSA, and filipin were from Sigma Chemical
Co. and 
 
n
 
-octylglucoside was from Boehringer Mannheim. Tran
 
35
 
S-label
and 
 
125
 
I-NaI were from DuPont-NEN. Synthesis and radioiodination of
IC16 (16-iodohexadecanoic acid) and IC13 (13-iodotridecanoic acid) fatty
acid analogues were performed as previously described (2).
 
Plasmid Construction
 
Construction of plasmids containing wild-type Fyn, G
 
2
 
A-Fyn, C
 
3,6
 
S-Fyn,
and G
 
a
 
o
 
-Fyn was described before (1, 41). For generation of K
 
7
 
A-, K
 
9
 
A-,
K
 
7,9
 
A-Fyn, and Lck(10)Fyn constructs, sense oligonucleotides were syn-
thesized to encode the upstream region of pGEM3Z, an NcoI site, and ei-
ther the first 11–14 amino acids of human Fyn, containing lysines to ala-
nine substitutions at positions 7 and/or 9, or the first 10 amino acids of
human Lck, followed by amino acids 11–16 of human Fyn. An antisense
oligonucleotide was used corresponding to a region of the SH3 domain of
Fyn (1). Sense and antisense primers were used with pGEM3Z-Fyn as a
template to generate mutant cDNAs, which were digested with NcoI and
BstXI to produce 76-bp fragments that were used to replace the cor-
responding fragments of Fyn in pSP65. A G
 
2
 
A-FynKRas construct was
generated by PCR using a sense oligonucleotide encoding nucleotides
1110–1130 of human Fyn containing a unique BglII site, and an antisense
oligonucleotide corresponding to the last 18 nucleotides of Fyn, followed
by the last 54 nucleotides of KRas4B, a stop codon, and a SalI site. The
primers were used with pGEM3Z-Fyn as a template. The PCR product
was digested with BglII and SalI to produce a 500-bp fragment that was
used to replace a corresponding carboxy-terminal fragment of G
 
2
 
A-Fyn in
pSP65. All Fyn constructs in pSP65 were subsequently digested with
EcoRI and SalI, and ligated into pCMV5. FynKRas was subsequently
generated by digestion of pCMV5-G
 
2
 
A-FynKRas with BglII and SalI, fol-
lowed by ligation into BglII and SalI cut pCMV5-Fyn. G
 
2
 
A,C
 
3
 
S-FynKRas
was generated by PCR, with pGEM3Z-Fyn as a template, using a sense
oligonucleotide encoding an NcoI site followed by the first eight amino ac-
ids of human Fyn, containing a glycine-to-alanine substitution at position
2 and a cysteine-to-serine substitution at position 3, and an antisense oli-
gonucleotide corresponding to the SH3 domain of Fyn (1). The PCR
product was digested with NcoI and BstXI to generate a 76-bp fragment
that was used to replace the corresponding fragment of pSP65-FynKRas.
G
 
2
 
A,C
 
3
 
S-FynKRas subcloned into pCMV5 as described above. 
 
D
 
SH2-Fyn
was subcloned into pSP65 by digestion of pSV
 
D
 
SH2-Fyn with BstXI and
BstE2 and ligation into BstXI- and BstE2-digested pSP65, and subcloned
into pCMV5, as described above. K
 
299
 
M-Fyn and R
 
176
 
K-Fyn constructs
were generated using the Quickchange site-directed mutagenesis kit
(Stratagene Inc.). Fyn(16)-GFP was generated by PCR, using a sense oli-
gonucleotide, encoding an EcoRI site followed by the first 16 amino acids
of human Fyn fused in frame to amino acid 2 of eGFP, and an antisense
oligonucleotide corresponding to the carboxy terminus of eGFP and an
XbaI site. These primers were used with pEGFP-N1 as a template to gen-
erate a 1.6-kb DNA fragment that was digested with EcoRI and XbaI, fol-
lowed by ligation into pCMV5.
 
Cell Culture and Transfection
 
COS-1 cells (American Type Culture Collection) were cultured and trans-
fected as previously described (41). For cotransfection experiments with
Fyn and NMT, 2 
 
m
 
g Fyn cDNA was used with 4 or 10 
 
m
 
g NMT cDNA (ra-
tios 1:2 and 1:5). For CD8-
 
z
 
 coimmunoprecipitation experiments, 5 
 
m
 
g 
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pEFBOS-CD8-
 
z
 
 was used with 5 
 
m
 
g pCMV5-Fyn construct and 10 
 
m
 
g
pCMV5-NMT or pCMV5.
 
Metabolic Radiolabeling, Cell Fractionation and 
Pretreatment with 2-Hydroxymyristate and Filipin
 
Transfected COS-1 cells were starved for 1 h at 37
 
8
 
C in DMEM minus me-
thionine/cysteine, supplemented with 2% dialyzed FBS, and labeled for
4 h at 37
 
8
 
C with 25 
 
m
 
Ci/ml Tran
 
35
 
S-label. For radiolabeling with fatty acid
analogues, cells were starved for 1 h at 37
 
8
 
C in DMEM containing 2% dia-
lyzed FBS, followed by radiolabeling for 4 h at 37
 
8
 
C with either 25 
 
m
 
Ci/ml
 
125
 
I-IC13 or 
 
125
 
I-IC16 (1, 41). Fractionation into cytosolic (S100) and total
membrane (P100) fractions and extraction with the nonionic detergent
Triton X-100 was performed as described previously (41). 2-Hydroxy-
myristate was stored as a 100-mM stock solution in DMSO and used for
experiments at 1 mM in DMEM containing 1% defatted BSA. Before ad-
dition to cells, 1 mM 2-hydroxymyristate solution was sonicated briefly
and filtered to remove any undissolved myristate analogue. After preincu-
bation for 2 h at 37
 
8
 
C, DMEM containing 5% FBS was added, followed by
overnight incubation at 500 
 
m
 
M 2-hydroxymyristate. Where indicated,
cells were pretreated for 1 h at 37
 
8
 
C with 10 
 
m
 
g/ml filipin in DMEM con-
taining 1% defatted BSA.
 
Immunoprecipitation, Gel Electrophoresis, and 
Quantitation of Fatty Acylation
 
For immunoprecipitation, each clarified lysate in RIPA buffer (10 mM
Tris/HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1%
SDS, 1% deoxycholate) was mixed with 3 
 
m
 
l anti–Fyn or 3 
 
m
 
l anti–GFP
and 10 
 
m
 
l protein A–agarose solution, and incubated for 2–12 h at 4
 
8
 
C. Im-
munoprecipitates were washed twice with RIPA buffer, once with STE
(50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA), resuspended in
SDS sample buffer containing 0.1 M DTT, and applied to SDS-PAGE.
Radiolabeled proteins in dried gels were visualized by exposure for 8–24 h
to X-Omat or BioMax film (Eastman Kodak Co.) or to PhosphorImager
screens. Quantitation of radiolabeled proteins was performed using the
ImageQuant software provided with the PhosphorImager system (Molec-
ular Dynamics, Inc.). In each labeling experiment, constructs were labeled
in duplicate with 
 
125
 
I-IC13, 
 
125
 
I-IC16, or Tran
 
35
 
S-label, and the mean of
the duplicates was calculated and used as the value for each individual ex-
periment. Numbers were corrected for the background in each individual
lane of the gel. Efficiency of myristoylation was calculated as 
 
125
 
I-IC13 in-
corporation per unit of 
 
35
 
S-label, which is accurate since all Fyn constructs
used in this report (see Table I) contain identical amounts of methionines
and cysteines. Numbers for myristoylation of mutant constructs were ex-
pressed relative to wild-type Fyn within each experiment. Each construct
was analyzed in two to four experiments.
 
CD8-
 
z
 
 Coimmunoprecipitation Experiments 
 
10% wt/vol stock solutions of high purity digitonin (Calbiochem Corp.)
were prepared according to the manufacturer’s instructions. After pro-
longed storage at 4
 
8
 
C, stocks produce precipitates that were removed by
reheating and filtration. For experiments, digitonin lysis buffer (1% digi-
tonin, 25 mM Tris, pH 8.0, 150 mM NaCl, 300 mM KCl, 25 mM NaF, 0.1 mM
Na
 
3
 
VO
 
4
 
) was prepared freshly using a clear 10% digitonin stock. Trans-
fected COS-1 cells were lysed for 15 min at 4
 
8
 
C in digitonin buffer supple-
mented with protease inhibitors (1.5 
 
m
 
g/ml of each leupeptin, aprotinin,
and pepstatin A [Boehringer Mannheim], 20 
 
m
 
g/ml each of AEBSF,
TLCK, TPCK, and benzamidine [Calbiochem Corp.]). Where indicated,
the digitonin lysis buffer was supplemented with 60 mM 
 
n
 
-octylglucoside.
Lysates were centrifuged for 15 min at top speed in an Eppendorf mi-
crofuge at 4
 
8
 
C and incubated for 4 h at 4
 
8
 
C with 2 
 
m
 
l anti–CD8 antibody
solution and 10 
 
m
 
l protein A/G
 
1
 
 agarose, or with 10 
 
m
 
l protein A/G
 
1
 
 aga-
rose alone. The anti–CD8 immunoprecipitates were centrifuged for 2 min
at top speed in an Eppendorf centrifuge, washed twice with digitonin
buffer, and once with ST buffer (10 mM Tris, pH 7.4, 150 mM NaCl).
Western blotting analysis for Fyn was performed as described (43), using a
rabbit anti–Fyn polyclonal in the primary antibody step. To evaluate the
levels of CD8-
 
z
 
 expression, Fyn blots were stripped and reprobed with
monoclonal anti–CD8 solution. As controls for total Fyn expression, su-
pernatants of the anti–CD8 immunoprecipitation step were supplemented
with 5
 
3 
 
RIPA buffer, 3 
 
m
 
l rabbit anti–Fyn antibody, 10 
 
m
 
l protein A–aga-
rose and incubated for 
 
.
 
4 h at 4
 
8
 
C. Immunoprecipitates were washed
 
three times in RIPA buffer and subjected to Western blotting using mono-
clonal antibody against Fyn (Transduction Laboratories) (43).
 
Results
 
Replacement of Lysines 7 and 9 in Fyn Results in 
Reduced Fatty Acylation and Membrane Anchoring
 
The first set of experiments was designed to quantitatively
assess the contributions of lysine residues within the Fyn
SH4 motif towards fatty acylation. COS-1 cells were trans-
fected with cDNAs encoding either wild-type Fyn, G
 
2
 
A-
Fyn, or the K
 
7,9
 
A-Fyn construct, in which lysines at posi-
tions 7 and 9 are replaced by alanine residues (Table I).
Radiolabeling with Tran
 
35S-label, followed by immuno-
precipitation of Fyn, SDS-PAGE and autoradiography,
showed that all constructs were expressed at similar levels
(Fig. 1). The K7,9A-Fyn construct displayed moderately el-
evated levels of expression and migrated as a doublet
(Fig. 1). Wild-type Fyn was labeled with both 125I-IC13
(a myristate analogue) and 125I-IC16 (a palmitate ana-
logue), while G2A-Fyn was not (Fig. 1, and Table II), as
described previously (1, 41, 43). Although the K7,9A-Fyn
construct contains both the glycine at position 2 and the
cysteine at position 3 required for efficient myristoylation
and palmitoylation of Fyn (1, 41, 43), levels of 125I-IC13
and 125I-IC16 incorporation were drastically reduced (Fig.
1). In subsequent experiments, K7A-Fyn and K9A-Fyn
mutants, containing alanine replacements of either lysine
7 or 9, were included to analyze the relevance of the in-
dividual lysines for fatty acylation. Radiolabeling with
Tran35S-label and 125I-IC13, followed by calculation of ex-
pression levels and relative myristoylation (Table II),
showed that mutation of lysine 7 or 9 individually reduced
myristoylation of Fyn by 51 and 40%, respectively (Table
II). Myristoylation of the double mutant, K7,9A-Fyn, was
inhibited by 83% (Table II), implying that the effect of
each lysine mutation on myristoylation is additive. In
agreement with the dependence of palmitoylation on
myristoylation, the level of 125I-IC16-palmitate labeling of
K7,9A-Fyn was also found to be reduced to 22 6 3% (n 5
4) of wild-type levels.
Lck is the only Src family member that lacks lysines at
positions 7 and 9 (36, 37). Quantitative analysis of fatty
acylation of full length Lck was hampered by inconsistent
immunoprecipitation results using different batches of
Table I. NH2-terminal Sequences of Wild-Type and Mutant
Fyn Constructs
Amino acid position
234567891 0
F y n GCVQCKDKE
G2A-Fyn A CVQCKDKE
C3,6S-Fyn G S VQSKDKE
K7A-Fyn G C V Q C A DKE
K9A-Fyn G C V Q C K D A E
K7,9A-Fyn G C V Q C A DAE
L c k GCGCSSHPE
Gao GCTLSAEER
Sequences of the first ten amino acids of each Fyn construct are shown with mutant
amino acids underlined.The Journal of Cell Biology, Volume 145, 1999 380
anti–Lck antibody. Therefore, to test whether the absence
of lysines 7 and 9 impairs myristoylation of the Lck amino
terminus, we used an Lck(10)Fyn fusion construct (Table
I). As shown in Table II, myristoylation of Lck(10)Fyn
was very similar (z90%) to that of Fyn, and palmitoyla-
tion of Lck(10)Fyn was z1.43 more efficient than that of
Fyn (data not shown). These results show that despite the
lack of lysines 7 and 9 in Lck, the overall fatty acylation
profile at its amino terminus is very similar to that of Fyn.
It is relevant to note that Lck contains a serine at position
6 (Table II), a preferred residue at this site for mammalian
NMT recognition (17).
Since fatty acylation of Fyn is essential for membrane
binding (1, 41, 43), the reduced levels of fatty acid modifi-
cation of K7,9A-Fyn would be expected to alter the subcel-
lular distribution of this construct. Transfected cells ex-
pressing the various Fyn constructs were radiolabeled with
Tran35S-label, 125I-IC13 or 125I-IC16, followed by homoge-
nization and fractionation into high-speed supernatant
(S100) and membrane (P100) fractions, and the distribu-
tion of Fyn was analyzed. Fig. 2 shows that more than 95%
of wild-type Fyn was recovered from the membrane frac-
tion as dually acylated protein, whereas z75% of G2A-
Fyn was recovered from the soluble fraction, in agreement
with previous results (1, 41, 43). In addition, slightly more
than 50% of K7,9A-Fyn was found in the soluble fraction
(Fig. 2 B), specifically consisting of the protein band with
the slower migration, that is neither myristoylated nor
palmitoylated (A). The reason for this difference in migra-
tion is not clear, and it cannot be explained simply by the
absence of fatty acylation since the G2A-Fyn mutant does
not show this effect. The remainder of K7,9A-Fyn was re-
covered from the membrane fraction as dually acylated
protein (Fig. 2 A). The calculated ratio of 125I-IC13 label
to Tran35S-labeled in the P100 fraction was 25% lower for
K7,9A-Fyn compared with wild-type Fyn (data not shown),
implying that some of the protein in the membrane frac-
tion is not acylated. This is confirmed by the results with
G2A-Fyn, for which z25% of the protein is found in the
membrane pellet, even though none of the protein is fatty
acylated (Fig. 2 and Table II).
Overexpression of Enzymatically Active NMT Rescues 
the Impaired Fatty Acylation and Membrane Binding
of K7,9A-Fyn
Cotransfection experiments were performed to investigate
whether the reduced myristoylation of the K7,9A-Fyn mu-
tant was related to levels of NMT activity inside cells.
COS-1 cells were transfected with Fyn or K7,9A-Fyn
cDNA alone (Fig. 3, lanes 1 and 2), or cotransfected with
cDNA encoding either wild-type NMT (lanes 3 and 4) or
Figure 1. Fatty acylation of Fyn,
G2A-Fyn, and K7,9A-Fyn in
COS-1 cells. COS-1 cells were
transfected with cDNAs encod-
ing wild-type Fyn, G2A-Fyn, and
K7,9A-Fyn, and radiolabeled
with either Tran35S-label, 125I-
IC13, or 125I-IC16. Cell lysates
were immunoprecipitated with anti–Fyn antibody and analyzed
by SDS-PAGE and autoradiography. Gels were exposed to film
for 8–24 h, and strips corresponding to the region of the gel con-
taining p59Fyn are shown. No other radiolabeled proteins were
apparent on the gel.
Table II. Relative Myristoylation Levels of Wild-Type and 
Mutant Fyn Constructs in COS-1 Cells
Construct
125I-IC13 incorporation per 35S-labeled unit of Fyn protein
35S-Met 125I-IC13 125I-IC13/35S-Met n
Fyn 100% 100% 100% 8
G2A-Fyn 87 6 51   6 10 2
K7A-Fyn 145 6 8 73 6 6 49 6 22
K9A-Fyn 195 6 6 116 6 8 60 6 42
K7,9A-Fyn 160 6 12 28 6 6 17 6 35
Lck(10)Fyn 125 6 3 104 6 3 91 6 32
COS-1 cells were transfected with Fyn cDNA as indicated and radiolabeled as de-
scribed in Fig. 1. Gels were exposed to PhosphorImager screens for 24 or 48 h, and in-
corporation of Tran35S-label or 125I-IC13 into wild-type and mutant Fyn was mea-
sured using the ImageQuant software provided with the PhosphorImager system.
Values for 35S-label in Fyn ranged from 50,000 to 200,000 PhosphorImager units, and
for 125I-labeled Fyn from 10,000 to 50,000 units. Background numbers comprised
5–10% of total values for both labeling procedures. Incorporation of radiolabel into
the Fyn constructs is expressed relative to wild type. n, number of experiments per-
formed for each construct.
Figure 2. Fatty acylation and subcellular distribution of Fyn,
G2A-Fyn, and K7,9A-Fyn in COS-1 cells. (A) Transfected cells
were radiolabeled with either Tran35S-label, 125I-IC13, or 125I-
IC16. Cells were homogenized and fractionated into S100 (S) and
P100 (P) fractions, followed by immunoprecipitation, SDS-
PAGE, and autoradiography. Gels were exposed to film for
8–24 h. (B) Quantitation of the subcellular distribution of 35S-
labeled wild-type and mutant Fyn by PhosphorImaging. Gels
were exposed to PhosphorImager screens for 8–24 h. Values rep-
resent the mean of four independent experiments.vanÕt Hof and Resh Membrane Localization of Fyn and TCR z Interaction 381
H218N-NMT (lanes 5 and 6). H218N-NMT contains a point
mutation in the active site that abolishes transfer of myri-
stoyl-CoA to protein (28), and serves as a negative control
for the requirement of NMT activity. The ratio of NMT
cDNA to Fyn cDNA used for transfection was 2:1. Fig. 3
shows that Fyn (lanes 1, 3, and 5) and K7,9A-Fyn protein
(lanes 2, 4, and 6) were expressed at similar levels, with
K7,9A-Fyn exhibiting an extra band with a slower migra-
tion and reduced myristoylation relative to wild-type Fyn
(compare lanes 1 and 2). Cotransfection of K7,9A-Fyn with
wild-type NMT increased 125I-IC13 labeling two- to three-
fold (compare Fig. 3, lanes 1 and 2 with lanes 3 and 4, and
see Fig. 4 B), whereas cotransfection with enzymatically
inactive H218N-NMT had no effect (compare Fig. 3, lanes 1
and 2 with lanes 5 and 6). Cotransfection of K7,9A-Fyn
with wild-type NMT also increased 125I-IC16 incorpora-
tion of K7,9A-Fyn twofold (data not shown). In addition,
the relative intensity of the lower band in the K7,9A-Fyn
doublet increased (Fig. 3, lane 4), consistent with an in-
crease in fatty acylation levels.
The data in Figs. 1–3 imply that levels of endogenous
NMT in COS-1 cells are limiting for myristoylation of
K7,9A-Fyn. To verify this supposition, the effect of varying
the ratio of NMT cDNA to Fyn cDNA was tested. Myri-
stoylation levels of K7,9A-Fyn increased twofold, using
twice the amount of NMT cDNA and three- to fivefold us-
ing five times more NMT cDNA (Fig. 4 B). No significant
effect on myristoylation of wild-type Fyn was observed
(Fig. 4 A), implying that the amount of endogenous NMT
was sufficient to achieve maximal myristoylation levels of
this protein. Analysis of NMT expression by Western blot-
ting confirmed that increasing levels of NMT protein were
expressed after cotransfection with NMT cDNA (data not
shown). Radiolabeling with Tran35S-label, followed by
subcellular fractionation, showed that the distribution of
wild-type Fyn between the soluble and the membrane
fraction was not affected during coexpression of NMT
Figure 3. Myristoylation of wild-type Fyn and K7,9A-Fyn coex-
pressed in COS-1 cells with wild-type or mutant NMT. Cotrans-
fection of Fyn and NMT constructs in COS-1 cells was performed
using 2 mg Fyn cDNA and 4 mg NMT cDNA. Radiolabeling of
transfected cells, followed by immunoprecipitation, SDS-PAGE,
and autoradiography was performed as described in Materials
and Methods.
Figure 4. Myristoylation efficiency and subcellular distribution
of wild-type Fyn and K7,9A-Fyn after cotransfection in COS-1
cells with varying amounts of NMT cDNA. Cotransfection of Fyn
and NMT constructs in COS-1 cells was performed as described
in Materials and Methods, using 2 mg Fyn cDNA and 0, 4, or 10 mg
NMT cDNA. Radiolabeling of cells transfected with (A) wild-
type Fyn or (B) K7,9A-Fyn, followed by immunoprecipitation,
SDS-PAGE, and quantitation of 125I-IC13 incorporation per unit
35S-labeled protein by PhosphorImaging was performed as de-
scribed in Table II. Values are expressed relative to wild-type
Fyn, expressed in the absence of exogenous NMT, and numbers
represent the mean of four independent experiments. (C) Radio-
labeling of cells transfected with 2 mg Fyn or K7,9A-Fyn cDNA
and 4 mg NMT cDNA, followed by homogenization and subcellu-
lar fractionation. Analysis of protein distribution was performed
as described in Fig. 2. Values represent the mean of four inde-
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(Fig. 4 C). In contrast, K7,9A-Fyn expressed in the pres-
ence of NMT displayed a significant shift from the soluble
to the membrane fraction (Fig. 4 C). Taken together, these
experiments demonstrate that the fatty acylation defect of
the K7,9A-Fyn mutant can be restored by expressing excess
amounts of exogenous NMT.
Coimmunoprecipitation of Fyn with the z Chain of the 
TCR Depends on the Fatty Acylation Status of Fyn
The ability to manipulate fatty acylation of Fyn provided
us with a unique opportunity to quantitate the individual
contributions of the fatty acids and the surrounding amino
acids towards interactions of Fyn with other membrane
bound proteins. We chose to evaluate the interactions of
Fyn with the z chain of the TCR complex as a model sys-
tem. COS-1 cells were cotransfected with cDNAs for Fyn
and CD8-z, a chimeric construct containing the extracellu-
lar and transmembrane regions of CD8, fused to the cyto-
plasmic tail of the TCR z chain (16). Cells were lysed in a
1% digitonin lysis buffer (10, 33) and subjected to immu-
noprecipitation with anti–CD8 monoclonal antibody. In-
cubation with protein A/G1 agarose beads alone was used
as a negative control. When anti–CD8 immunoprecipitates
were analyzed by Western blotting using polyclonal anti–
Fyn antibody, a signal for Fyn was obtained using lysates
from cells coexpressing Fyn and CD8-z (Fig. 5 A, lane 3).
Relative to the amount of wild-type Fyn, only marginal
amounts (,5%) of G2A-Fyn and C3,6S-Fyn were detected
after immunoprecipitation with anti–CD8 antiserum (Fig.
5,  A, lanes 5 and 7, and B). Since G2A-Fyn is neither
myristoylated nor palmitoylated and C3,6S-Fyn is myri-
stoylated but not palmitoylated (1, 43), these data indicate
that fatty acylation of Fyn with both myristate and palmi-
Figure 5. Coimmunoprecipita-
tion of wild-type or mutant Fyn
constructs with CD8-z. (A)
COS-1 cells were cotransfected
with cDNAs encoding wild-type
or mutant Fyn (see Table I),
CD8-z, and NMT where indi-
cated. Cells were lysed in digito-
nin buffer and subjected to
immunoprecipitation with anti–
CD8 monoclonal antibody (1)
or with protein A/G1 agarose
beads alone (2). Immuno-
precipitates were analyzed by
SDS-PAGE and Western blot-
ting using polyclonal anti–Fyn
antibody (top). Subsequently,
the blot was stripped and re-
probed using anti–CD8 mono-
clonal antibody; the distribution
of the 41-kD form of CD8-z is
shown (middle). After immuno-
precipitation with anti–CD8 an-
tibody, lysates were subjected to
a second immunoprecipitation
step, using polyclonal anti–Fyn
antibody, followed by SDS-
PAGE and Western blotting us-
ing monoclonal anti–Fyn anti-
body (bottom). (B) Levels of
Fyn protein coimmunoprecipi-
tating with CD8-z were quanti-
fied by scanning of films. Films
were exposed for different times
to the blot and measurements
were made in the linear range of
the film. The measured values
for coimmunoprecipitation with
CD8-z were corrected for total
expression levels and values are
expressed relative to the amount
of wild-type Fyn that coim-
munoprecipitates with CD8-z.
Given values represent the
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tate is required for association of Fyn with CD8-z. K7,9A-
Fyn was also impaired (z70%) in its ability to coimmuno-
precipitate with CD8-z (Fig. 5), a result similar to that
obtained by Gauen et al. (11) for association of K7,9A-Fyn
with a VSV G-z chimera. However, the level of coimmu-
noprecipitation of K7,9A-Fyn with CD8-z could be in-
creased twofold by overexpression of exogenous NMT
(Fig. 5, A, lane 11, and B) and this correlates well with the
twofold increase in myristoylation levels (Fig. 4 B). This
gain of function experiment indicates that the presence of
lysine residues at positions 7 and 9 in Fyn is not required
per se for an interaction with the z chain, but rather for ef-
ficient fatty acylation of Fyn. In addition, Gao-Fyn (41)
and Lck(10)Fyn, fusion proteins in which the first 10
amino acids of Fyn are replaced with those of human Gao
or human Lck (Table I) were analyzed. Both constructs
are efficiently dually fatty acylated (see reference 41 and
Table II), yet their NH2-terminal sequences are distinct
from that of Fyn outside the met-gly-cys motif (Table I).
As depicted in Fig. 5  B, the levels of Gao-Fyn and
Lck(10)Fyn coimmunoprecipitating with CD8-z were sim-
ilar (z90%) to that of wild-type Fyn (Fig. 5 B), providing
two additional examples of the need for dual fatty acyla-
tion rather than specific lysine residues for interaction of
Fyn with CD8-z. Controls indicated that expression levels
of CD8-z and Fyn constructs were constant throughout the
experiments (see Fig. 5 A).
Inhibition of Myristoylation, Membrane Binding, and 
CD8-z Association of Wild-Type Fyn by Treatment
with 2-Hydroxymyristate
In an attempt to manipulate fatty acylation levels of wild-
type Fyn, the effect of 2-hydroxymyristate, a potent inhibi-
tor of NMT (25, 27) was tested. Transfected COS-1 cells
expressing wild-type Fyn were treated with 2-hydroxy-
myristate and radiolabeled with either Tran35S-label or
125I-IC13. Analysis of immunoprecipitated Fyn after
SDS-PAGE showed that the level of 35S-labeled protein
was unaffected but that the level of 125I-IC13 labeling
was significantly decreased (83%) after treatment with
2-hydroxymyristate (Fig. 6 A). Subsequently, analysis of
the subcellular distribution of Fyn after treatment with
2-hydroxymyristate showed a dramatic increase in the
amount of soluble Fyn. More than 95% of Fyn was recov-
ered from the membrane P100 fraction of control cells,
whereas .40% was observed in the soluble fraction after
2-hydroxymyristate treatment (Fig. 6 A). Next, the effect
on coimmunoprecipitation of wild-type Fyn with CD8-z
was analyzed. 2-Hydroxymyristate treatment caused a sig-
nificant decrease in the amount of wild-type Fyn coimmu-
noprecipitating with CD8-z (Fig. 6 B), to ,40% of control
levels. After 2-hydroxymyristate treatment, wild-type Fyn
still retains glycine 2, cysteine 3, and lysines 7 and 9, all of
the residues previously implicated as part of an ITAM
binding motif on Fyn, yet it cannot associate with z.
Association of Fyn with z Chain: The NH2 Terminus of 
Fyn Alone Is Not Sufficient and Functional SH2- and 
SH1-kinase Domains Are Essential
To further define the nature of the observed association
between Fyn and TCR z, the following series of experi-
ments was performed. Fig. 7 A shows that between 10 and
15% of the total population of Fyn coimmunoprecipitated
with CD8-z (compare lanes 7 and 11). Fyn protein was not
detected in the absence of anti–CD8 antibody during im-
munoprecipitation (Figs. 5–7), showing that nonspecific
binding of Fyn to the protein A/G1 agarose beads did not
occur. Fyn was only detected in anti–CD8 immunoprecipi-
tates from cells expressing both CD8-z and Fyn (Figs. 5 A,
lane 3, 6 B, and 7 A, lane 7), but not from mock trans-
fected cells (Fig. 7 A, lane 1), cells expressing CD8-z alone
(Figs. 5 A, lane 1, and 7 A, lane 3), or Fyn alone (Fig. 7 A,
lane 5). In addition, the mixing of digitonin lysates of cells
that were transfected separately with either Fyn or CD8-z,
followed by immunoprecipitation with anti–CD8-z anti-
bodies, did not result in coimmunoprecipitation of Fyn
(Fig. 7 A, lane 9), highlighting that Fyn and CD8-z need to
be present within the same cell.
Next, the functional requirements within the Fyn pro-
tein structure for association with CD8-z were evaluated.
We first tested whether the Fyn NH2 terminus alone is suf-
ficient for interaction with the z chain in cells, using
Fyn(16)GFP, a chimeric construct containing the first 16
amino acids of Fyn fused to GFP. Fyn(16)GFP expressed
in COS-1 cells was dually acylated with myristate and
palmitate (data not shown), and after extraction with non-
ionic detergent buffer, z60% of total Fyn(16)GFP was re-
Figure 6. Myristoylation, subcellular distribution, and coimmu-
noprecipitation of Fyn with CD8-z after 2-hydroxymyristate
treatment. Transfected cells expressing Fyn were preincubated
overnight with 500 mM 2-hydroxymyristate, as described in Mate-
rials and Methods. (A) Cells were radiolabeled in the absence
(2) or presence (1) of 500 mM 2-hydroxymyristate with Tran35S-
label, or 125I-IC13, and analyzed directly (left) or subjected to ho-
mogenization and subcellular fractionation, followed immuno-
precipitation (right). (B) COS-1 cells were cotransfected with
cDNAs for Fyn and CD8-z, and incubated in the absence (2) or
the presence (1) of 2-hydroxymyristate. Cells were lysed in digi-
tonin buffer and coimmunoprecipitation of Fyn with CD8-z was
analyzed using anti–CD8 antibody (1) or protein A/G1 agarose
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covered from the detergent insoluble fraction (Fig. 7 B).
Thus, Fyn(16)GFP is processed and targeted like wild-
type Fyn and other chimeras containing the Fyn SH4 motif
(41, 43). After coexpression of Fyn(16)GFP and CD8-z in
COS cells, followed by digitonin lysis, no Fyn(16)GFP was
detected in anti–CD8 immunoprecipitates, although there
was a strong signal after immunoprecipitation with anti–
GFP antibody (Fig. 7  B). Similar results were obtained
with constructs containing the NH2 terminus of Fyn fused
to GST or b galactosidase (data not shown). These results
indicate that the NH2-terminal SH4 motif of Fyn by itself
is not sufficient for association with CD8-z and that addi-
tional domains of the Fyn protein are required. To identify
these requirements, CD8-z was coexpressed with three dif-
ferent Fyn mutants: K299M-Fyn carries a point mutation in
the SH1 domain that renders Fyn kinase-inactive, DSH2-
Fyn lacks amino acids 144–248 encoding the Fyn SH2 do-
main, and R176K-Fyn contains a point mutation of a critical
arginine residue in the SH2 domains of Src family kinases
that reduces phosphotyrosine binding (26). Less than 15%
of DSH2-Fyn and only z35% of K299M-Fyn and R176K-
Fyn was detected in anti–CD8 immunoprecipitates (Fig. 7
C, left, and Table III). The expression levels were similar
for all constructs (Fig. 7 C, right). These findings establish
that functional SH1 and SH2 domains in Fyn are impor-
tant for optimal interaction with CD8-z.
Association of Fyn with z Chain Requires 
Phosphorylation of z ITAMs by Fyn
Based on the findings described above that kinase activity
and the SH2 domain in Fyn are critical, we addressed the
relevance of the ITAM motifs in the z chain for associa-
tion with Fyn. First, the tyrosine phosphorylation status of
CD8-z was tested by immunoprecipitation with anti–CD8
antibody followed by antiphosphotyrosine Western blot-
ting analysis. As shown in Fig. 8 A, CD8-z was strongly ty-
rosine phosphorylated when coexpressed with Fyn, DSH2-
Figure 7. Analysis of the molec-
ular determinants in Fyn re-
quired for coimmunoprecipita-
tion with CD8-z. (A) COS-1
cells were transfected with
empty pCMV5 vector (lanes 1
and 2), cDNA encoding CD8-z
alone (lanes 3 and 4), Fyn alone
(lanes 5 and 6), or cotransfected
with both CD8-z and Fyn (lanes
7, 8, 11, and 12). Cells were lysed
in digitonin buffer and subjected
to immunoprecipitation with
(1) or without (2) monoclonal
antibody against CD8 (lanes
1–10) or Fyn (lanes 11 and 12).
In addition, immunoprecipi-
tation was performed using a
mixed digitonin lysate, derived
from cells transfected separately
with CD8-z or Fyn (lanes 9 and
10). Immunoprecipitates were
analyzed by SDS-PAGE and
Western blotting using poly-
clonal anti–Fyn antibody. (B)
COS-1 cells were transfected
with Fyn(16)GFP cDNA and ei-
ther lysed in RIPA buffer and
subjected to immunoprecipita-
tion using anti–GFP antibody
(Total) or fractionated into 1%
Triton X-100 soluble (S) or re-
sistant (R) fractions before im-
munoprecipitation (left). For
coimmunoprecipitation analy-
sis, COS-1 cells were transfected
with Fyn(16)GFP and CD8-z cDNA, lysed in digitonin buffer, and subjected to immunoprecipitation with (1) or without (2) anti–GFP
or anti–CD8 antibody (right). Immunoprecipitates were analyzed by SDS-PAGE and Western blotting using polyclonal anti–GFP. (C)
COS-1 cells were transfected with cDNAs encoding CD8-z and either wild-type Fyn, K299M-Fyn, DSH2-Fyn, or R176K-Fyn. Digitonin
lysates were subjected to immunoprecipitation with anti–CD8 antibody (left) or anti–Fyn monoclonal antibody (right) and immunopre-
cipitates were analyzed by SDS-PAGE and Western blotting with anti–Fyn antibody. The locations of full length Fyn and DSH2-Fyn
are indicated by the arrows. The weak signal in the K299M-Fyn lane (left) may be accounted for by phosphorylation of CD8-z by endog-
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Fyn, or R176K-Fyn, but not when expressed alone or when
coexpressed with kinase dead K299M-Fyn. Levels of CD8-z
protein were constant (Fig. 8  A, bottom). As observed
elsewhere (18), CD8-z is present in three forms in COS-1
cells, migrating at 36, 38, and 41 kD, respectively (Fig. 8 A,
arrows). Comparison of the migration profiles indicated
that the 41-kD band and the smear above it represent the
tyrosine phosphorylated forms of CD8-z (Fig. 8 A, top ar-
row). Next, the specificity of z chain ITAM phosphoryla-
tion by Fyn was analyzed by use of a CD8-z construct in
which the cytoplasmic tail was truncated after the second
ITAM motif (CD8-zT76), and a CD8-zT76 construct in
which all four remaining ITAM tyrosines were mutated to
phenylalanine (CD8-z4F) (22). As measured by radiola-
beling and immunoprecipitation, the total levels of protein
expression in COS-1 cells were similar for each construct
(Fig. 8 B, bottom). Truncated CD8-zT76 was observed as
one main form that migrated at z40 kD and the major ra-
diolabeled form of CD8-z4F was observed to migrate at
z35 kD, as indicated by the arrows. The 40-kD band of
CD8-zT76 was tyrosine phosphorylated when coexpressed
with Fyn, with moderately reduced levels compared with
full length CD8-z, whereas no tyrosine phosphorylation
was observed for the CD8-z4F mutant (Fig. 8 B). Analysis
of the association of Fyn with the different CD8-z con-
structs showed that similar amounts (z90%) of Fyn co-
immunoprecipitated with CD8-zT76, whereas very little
(,20%) Fyn was observed in the CD8-z4F immunoprecip-
itate (Fig. 8  C, and Table III). These results show that
phosphorylation of ITAM tyrosines in the z chain by Fyn
is critical for association between Fyn and z. A similar
finding was reported by Pleiman et al. (29), who showed
that the SH2 domains of Fyn and Lyn bind to the tyrosine
phosphorylated ITAM in the Iga receptor.
Association of Fyn with CD8-z Is Stabilized in 
Membrane Rafts
Dual fatty acylation has previously been shown to be re-
quired for localization of Fyn to plasma membrane micro-
Table III. Quantitative Analysis of Coimmunoprecipitation of 
Fyn with CD8-z
Construct Relative coimmunoprecipitation
CD8-z1  Fyn 100%
1 K299M-Fyn 35%
1 DSH2-Fyn 14%
1 R176K-Fyn 38%
CD8-zT76 1 Fyn 91%
CD8-z4F 1 Fyn 19%
CD8-z 1 Fyn (Octylglucoside) 14%
(Filipin) 54%
CD8-z1   FynKRas 93%
1 G2A,C3S-FynKRas 26%
COS-1 cells were transfected with cDNAs encoding the indicated constructs, and
coimmunoprecipitation experiments were performed as described in Fig. 5. In each ex-
periment, coimmunoprecipitation of Fyn protein constract with anti–CD8 antibody
was measured in duplicate and multiple films representing different exposure times to
the blot were used to ensure linarity of the signal. These values were first corrected for
the total level of Fyn protein in each immunoprecipitation, as measured by the second
Fyn immunoprecipitation step (see Materials and Methods). Given numbers for each
test are expressed relative to the amount of wild-type Fyn that coimmunoprecipitates
with full length CD8-z and represent the mean of two experiments, with errors rang-
ing from 5 to 15%. The given 100% value of wild-type Fyn coimmunoprecipitating
with full length CD8-z represents 10–15% of total Fyn expressed (see Fig. 7).
Figure 8. Analysis of the molec-
ular interactions between Fyn
and CD8-z. (A) COS-1 cells were
transfected with cDNAs encod-
ing CD8-z and either pCMV5,
wild-type Fyn, K299M-Fyn,
DSH2-Fyn, or R176K-Fyn. Trans-
fected cells were lysed in RIPA
buffer and were subjected to im-
munoprecipitation with anti–
CD8 antibody, followed by
Western blotting analysis using
antiphosphotyrosine (a-PTyr)
monoclonal antibody (top). As
controls for expression levels,
transfected cells were radiola-
beled with Tran35S-label (bot-
tom), lysed in RIPA buffer, and
subjected to immunoprecipita-
tion with anti–CD8 antibody, fol-
lowed by SDS-PAGE and auto-
radiography. CD8-z expressed in
COS-1 cells is present in three
forms that migrate at 36, 38, and
41 kD, respectively, as indicated
by the arrows. The 41-kD form
represents the main tyrosine phosphorylated band. Overexposure of the blot in the top row revealed a low level of phosphorylation of
CD8-z in the pCMV5 and K299M lanes, presumably reflecting the activity of endogenous Fyn or other kinases. (B) COS-1 cells were
transfected with cDNAs encoding wild-type Fyn and either CD8-z, CD8-zT76, or CD8-z4F. Antiphosphotyrosine Western blotting and
radiolabeling were performed as described in A. Truncated CD8-zT76 was present in one main form that migrated at z40 kD while the
main radiolabeled form of CD8-z4F migrated at z35 kD, as indicated by the arrows. (C) COS-1 cells were transfected as described in B
and coimmunoprecipitation analysis of Fyn with CD8-z constructs was performed as described in Fig. 7 C, legend.The Journal of Cell Biology, Volume 145, 1999 386
domains known as rafts (5, 35, 38, 41, 43). To test for the
involvement of rafts in directing the interactions between
Fyn and z chain, two different approaches were used. First,
we analyzed the sensitivity of coimmunoprecipitation of
Fyn with CD8-z to treatment with octylglucoside and fil-
ipin, agents that disrupt raft stability (5, 38). The associa-
tion of Fyn with CD8-z was almost entirely abolished by
addition of octylglucoside to the digitonin lysis buffer (Ta-
ble III). The interaction was also greatly reduced (z50%)
by pretreatment of cells with filipin (Table III), an agent
that binds cellular cholesterol, an essential component for
raft integrity (5, 38). An alternate approach was based on
the recent observation that, in contrast to fatty acylated
proteins, farnesylated proteins are largely excluded from
detergent-resistant membrane rafts (23). Fyn was tagged
at the carboxy terminus with the KRas4B tail (FynKRas),
which promotes farnesylation and plasma membrane tar-
geting (15). This construct is both fatty acylated and
prenylated (data not shown). A second construct con-
taining only a functional farnesylation signal was gener-
ated by mutating the amino-terminal fatty acylation sites
(G2A,C3S-FynKRas). When expressed in COS-1 cells,
wild-type Fyn and the two KRas-tagged constructs were
completely membrane bound (Fig. 9 A). Wild-type Fyn
and FynKRas were also enriched in the Triton X-100 in-
soluble fraction (Fig. 9  B). In contrast, the amount of
G2A,C3S-FynKRas in the Triton X-100 insoluble fraction
was significantly lower (Fig. 9 B), suggesting that farnesy-
lated Fyn exhibits reduced association with plasma mem-
brane rafts. Fig. 9 C  and Table III show that coimmu-
noprecipitation of G2A,C3S-FynKRas with CD8-z was
significantly reduced, whereas association of FynKRas
with CD8-z was very similar to that of wild-type Fyn.
FynKRas and G2A,C3S-FynKRas kinase activity and abil-
ity to phosphorylate z ITAM tyrosines were similar to
wild-type Fyn (data not shown). These observations imply
that fatty acylation not only provides plasma membrane
binding of Fyn, but also guides specific localization to
membrane subdomains, which is essential for stabilization
of the protein–protein interactions between Fyn and the z
chain.
Discussion
Lysines 7 and 9 Are Required for Efficient
N-Myristoylation of Fyn
Lysine residues at positions 7 and 9 are conserved in
Figure 9. Membrane binding, Triton X-100 sensitivity, and coimmunoprecipitation of fatty acylated and farnesylated Fyn constructs.
(A) COS-1 cells were transfected with cDNAs encoding wild-type Fyn, FynKRas, or G2A,C3S-FynKRas. Transfected cells were radio-
labeled with Tran35S-label, homogenized, and fractionated as described in Materials and Methods. Distribution into the P100 fraction
was quantitated by phosphorimaging. Values represent the mean of two experiments. (B) COS-1 cells were transfected as described in
A, followed by fractionation into 1% Triton X-100 soluble (S) or resistant (R) fractions. Distribution of Fyn constructs into the TX100
resistant fraction was quantitated after immunoprecipitation by Western blotting analysis, as described in Materials and Methods. Val-
ues represent the mean of two experiments. (C) COS-1 cells were transfected as described in A and coimmunoprecipitation analysis of
Fyn protein with CD8-z was performed as described in Fig. 7 C, legend.vanÕt Hof and Resh Membrane Localization of Fyn and TCR z Interaction 387
nearly all Src family members (36, 37), and, in the context
of the NH2 terminus of v-Src, the lysine at position 7 is crit-
ical for efficient myristoylation (6, 19). We were therefore
interested in testing the fatty acylation status of K7,9A-Fyn,
a mutant containing alanine substitutions for lysines 7 and
9. To obtain sensitive measurements of myristoylation lev-
els, different Fyn constructs (Table I) were expressed at
high levels in COS cells, and radiolabeling with the io-
dinated myristate analogue 125I-IC13 was performed. Af-
ter immunoprecipitation and SDS-PAGE, quantitation of
125I-IC13 incorporation into Fyn was accomplished by
PhosphorImaging (2), which is not feasible after radiola-
beling with conventional 3H-labeled myristate analogues
used in other studies (11). Since all Fyn constructs used in
this report contain the same number of methionines and
cysteines, labeling with Tran35S-label in parallel gave
precise numbers for expression levels of the protein
backbone. Subsequent calculation of 125I-IC13 per unit of
35S-labeled protein provided a reliable measure of the effi-
ciency of myristoylation for wild-type and mutant Fyn
constructs.
Our results show that, as previously established for v-Src
(6, 19), lysine 7 is required for efficient myristoylation of
Fyn (Table II). In addition, we show that lysine 9 plays an
important role in guiding effective myristoylation of Fyn
(Table II). Interestingly, the effects of the individual lysine
replacements add up to the total effect observed with the
double K7,9A-Fyn mutant (Fig. 1, and Table II), suggesting
that each lysine residue plays an independent role. The
conclusion that these lysines are directly involved in a
myristoylation event is further substantiated by our find-
ing that the K7,9A-Fyn myristoylation defect is specifically
reversed by coexpression with wild-type human NMT, but
not with enzymatically impaired H218N-NMT (28) (Figs. 3
and 4).
Reversal of the K7,9A-Fyn myristoylation defect by ad-
ditional exogenous NMT in our experiments was almost
complete (Fig. 4 B). In the experiments described here, we
have used cDNA encoding a 49-kD form of human NMT
(28), which has full enzymatic activity in vitro and is capa-
ble of functionally complementing myristoylation defi-
ciency in yeast (9). Additional cellular forms of NMT, with
higher molecular weights (z60 kD) and different intracel-
lular distribution patterns, have been observed (14), and
recently a second mammalian NMT was characterized
(13). Most notably, missing from the 49-kD form of NMT
(9, 28) is an NH2-terminal sequence containing a polybasic
motif that is proposed to function in ribosomal targeting of
NMT (14), as well as other cotranslationally active en-
zymes, such as N-methionylaminopeptidases (21). We
have observed that neither the 60-kD form nor the NMT 1
or 2 isoforms (13) reverse the myristoylation defect in
K7,9A-Fyn more efficiently than the 49-kD form (data not
shown).
Lck is the only Src family member that lacks lysines at
positions 7 and 9 (36, 37) and one might question whether
myristoylation of Lck is impaired relative to the other
Src-related kinases. Since quantitation of fatty acylation of
full length Lck proved technically difficult, we used an
Lck(10)Fyn fusion construct (Table I). Our results show
that the fatty acylation profile of the Lck amino terminus
is very similar to that of Fyn (Table II), despite the ab-
sence of lysines 7 and 9. We infer that in Lck the serine at
position 6 (Table I), a preferred residue at this site for rec-
ognition by mammalian NMT (17) is sufficient to direct ef-
ficient fatty acylation of this sequence. If myristoylation
levels of full length Lck were substoichiometric, one would
expect that either its membrane association would not be
complete or that additional factors (e.g., CD4) would be
required to guide membrane binding of Lck. However,
nearly all of the Lck in cells appears to be membrane
bound (18, 46). Moreover, two recent studies have shown
that plasma membrane targeting of Lck can be achieved in
the absence of CD4 and that the first 10 amino acids of
Lck are sufficient for plasma membrane binding (4, 46).
These experiments imply that myristoylation and palmi-
toylation of full length Lck occur efficiently.
The NH2 Terminus of Fyn Directs Fatty Acylation and 
Membrane Localization, but Does Not Specify an ITAM 
Binding Motif
Several earlier reports have described coimmunoprecipi-
tation of the thymic isoform of Fyn with the TCR/CD3
complex (10, 12, 33). The association was only observed
under mild detergent conditions and the exact nature of
the interaction remained unclear. Recently, the first 10
amino acids of Fyn were shown to be essential for specific
binding of Fyn to the z subunit, as well as other chains of
the TCR complex in heterologous systems (10). On the ba-
sis of mutagenesis experiments, it was concluded that the
amino acids glycine 2, cysteine 3, and lysines 7 and 9 define
a motif for binding to ITAMs and for plasma membrane
localization (11).
Our results described here (Figs. 1–4), as well as earlier
work from our group and others (1, 35, 41, 43), indicate
that these amino acids within the Fyn SH4 domain are es-
sential for optimal fatty acylation and membrane binding
of Fyn. Using the coimmunoprecipitation of various Fyn
constructs with a CD8-z fusion protein (16) as a model, we
present three lines of evidence to demonstrate that the
Fyn SH4 domain does not represent a specific ITAM bind-
ing motif.
First, we show that the reduced coimmunoprecipitation
of the K7,9A-Fyn mutant with CD8-z (Fig. 5, and reference
11) is specifically reversed by overexpression of NMT (Fig.
5). The effect of NMT overexpression is to increase fatty
acylation and membrane binding of K7,9A-Fyn (Figs. 3 and
4). This gain of function experiment clearly establishes
that coimmunoprecipitation of Fyn with CD8-z does not
require lysines 7 and 9 per se, but their presence is crucial
for directing efficient fatty acylation. This conclusion is
further substantiated by the observations made with the
Gao-Fyn and Lck(10)Fyn constructs, which coimmunopre-
cipitate with CD8-z as efficiently as wild-type Fyn
(Fig. 5 B). The NH2-terminal sequences of Gao-Fyn and
Lck(10)Fyn do not contain lysines at position 7 and 9 (Ta-
ble I), but they are efficiently fatty acylated (reference 41,
and Table I). Second, the loss of function experiment with
2-hydroxymyristate (Fig. 6) shows that, even in the pres-
ence of all the amino acids proposed to constitute the
ITAM binding motif (glycine 2, cysteine 3, and lysines 7
and 9), coimmunoprecipitation of wild-type Fyn with
CD8-z can be ablated. Thus, loss of association of wild-The Journal of Cell Biology, Volume 145, 1999 388
type Fyn to CD8-z coincides with a reduction of fatty acy-
lation and membrane binding (Fig. 6). Third, Fyn(16)GFP
did not coimmunoprecipitate with CD8-z (Fig. 7 B), show-
ing that the first 16 amino acids of Fyn are not sufficient
for interaction with the ITAMs on z, in agreement with the
results of cross-linking studies (34). This implies that other
protein determinants in Fyn are involved in mediating the
interactions with z chain. Indeed, coimmunoprecipitation
of Fyn was observed to require both a functional kinase as
well as an SH2 domain (Fig. 7 C).
Colocalization of Fyn and z Chain in Cell Surface Rafts
Coimmunoprecipitation of Fyn with TCR subunits occurs
only under mild detergent conditions (10, 12, 33), which
has been taken as evidence for low affinity protein–pro-
tein interactions. Our findings with Fyn, and a recently
growing interest in membrane microdomains (5, 38), sug-
gests the involvement of additional mechanisms for stabili-
zation of the interactions between Src kinases and TCR
subunits, which is supported by several recent indepen-
dent reports (24, 44, 45). In biological membranes, espe-
cially plasma membranes, phase-separated “rafts” exist,
representing lipid domains enriched in cholesterol and
sphingolipids that provide scaffolds for clustering of trans-
membrane and peripherally associated proteins (5, 38).
These rafts or microdomains can be recovered from cells
using mild detergent conditions (5). There is growing evi-
dence that key components of TCR-mediated signaling
events are localized to rafts. For example, palmitoylation
of the T cell transmembrane protein LAT is essential for
localization in rafts and T cell tyrosine phosphorylation
events (45). Src family kinases, especially Fyn and Lck, are
constitutively localized in rafts via dual fatty acylation mo-
tifs (35, 41, 43). Activation of the TCR results in specific
accumulation of z chains in plasma membrane rafts (24).
In COS cells, z20% of CD8-z is in the detergent-insoluble
fraction (data not shown), similar to the distribution of the
z chain in resting T cells (7), and this may explain in part
why only a limited amount (,20%) of total Fyn coimmu-
noprecipitates with CD8-z in COS cells. The functional
significance of raft localization is evidenced by the finding
that disruption of cell surface rafts interferes with early T
cell signaling events (44). These observations establish a
connection between local accumulation of signaling mole-
cules in plasma membrane rafts and regulated T cell sig-
naling events.
Based on the results reported here and by others (35, 39,
41, 43), the following model emerges. Myristoylation and
palmitoylation within the NH2-terminal SH4 domain di-
rects Fyn into detergent-resistant plasma membrane rafts
and positions the downstream SH2 and kinase domains in
close proximity to the TCR z chain. Phosphorylation of
the z ITAMs by Fyn (Fig. 8) allows subsequent interaction
between the phosphorylated ITAMs and the Fyn SH2 do-
main (Figs. 7 and 8). Accumulation of Fyn and the z chain
in rafts increases the local concentration of both proteins
and drives their association. The stability and the extent of
Fyn SH2/z phosphotyrosine interaction is apparently de-
pendent on the integrity of the rafts since treatment with
octylglucoside and filipin, agents that disrupt rafts (5, 38),
results in dissociation of the Fyn/z complex (Table III),
presumably due to a decrease of the effective local protein
concentrations. This implies that the Fyn SH2/z phospho-
tyrosine interaction is relatively weak, as found for several
other SH2/phosphotyrosine interactions (20). In T cells,
dissociation of the Fyn SH2 domain from the z chain
would make ITAM phosphotyrosine residues on z accessi-
ble for binding to the SH2 domains of other signaling mol-
ecules, such as ZAP-70. This model explains why under-
myristoylated and underpalmitoylated forms of Fyn, that
are not efficiently membrane bound, as well as a farnesy-
lated Fyn construct that is not enriched in membrane sub-
domains (Fig. 9), do not interact well with the z chain.
These studies illustrate that the role of the NH2-terminal
SH4 motif is to properly position Src kinases within spe-
cific locations of cellular membranes for optimal interac-
tion of downstream Src homology domains with other
membrane-bound signaling molecules.
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